https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46772 Wed 30 Nov 2022 13:07:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42518 Wed 24 Aug 2022 11:55:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41818 Wed 19 Apr 2023 09:35:08 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55102 Wed 10 Apr 2024 08:53:44 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42916 Wed 07 Sep 2022 10:15:26 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42967 Wed 07 Feb 2024 16:43:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41418 Wed 03 Aug 2022 11:59:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55023 Wed 03 Apr 2024 15:27:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54492 Tue 27 Feb 2024 15:12:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50428 Tue 25 Jul 2023 18:54:37 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35825 Tue 10 Dec 2019 11:47:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49986 Thu 22 Jun 2023 12:27:39 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47420 Thu 19 Jan 2023 12:56:37 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42064 Staphylococcus aureus bacteremia, Clostridium difficile infection, and vancomycin-resistant enterococci infections prevented in the intervention phase based on estimated reductions in the relative risk of infection. Changes to costs were defined as the cost of implementing the bundle minus cost savings from fewer infections. Health benefits gained from fewer infections were measured in quality-adjusted life-years (QALYs). Cost-effectiveness was evaluated using the incremental cost-effectiveness ratio and net monetary benefit of adopting the cleaning bundle over existing hospital cleaning practices. Results: Implementing the cleaning bundle cost $349 000 Australian dollars (AUD) and generated AUD$147 500 in cost savings. Infections prevented under the cleaning bundle returned a net monetary benefit of AUD$1.02 million and an incremental cost-effectiveness ratio of $4684 per QALY gained. There was an 86% chance that the bundle was cost-effective compared with existing hospital cleaning practices. Conclusions: A bundled, evidence-based approach to improving hospital cleaning is a cost-effective intervention for reducing the incidence of HAIs.]]> Thu 18 Aug 2022 11:06:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55116 Thu 11 Apr 2024 08:20:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40311 Thu 07 Jul 2022 17:03:37 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42349 Thu 04 Apr 2024 11:57:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42697 Thu 01 Sep 2022 09:44:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42693 Thu 01 Sep 2022 09:27:28 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7639 Sat 24 Mar 2018 08:36:02 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1666 Sat 24 Mar 2018 08:30:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5313 Sat 24 Mar 2018 07:45:59 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39038 Mon 29 Jan 2024 17:52:28 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37705 2.5 cfu/cm2 to indicate hygiene failure. Results: There were low levels of microbial contamination in the unit for baseline; DHP; and no DHP phases: 2.2% (95% CI 0.7-5.4%) vs 7.7% (95% CI 4.3-13.0%) vs 6% (95% CI 3.2-10.4%) hygiene failures, respectively. Significant reduction in ACCs did not occur when the DHP was operating compared with baseline and control phases. Conclusion: Further work is needed to determine whether continuous DHP technology has a role in decontamination for healthcare settings.]]> Mon 22 Mar 2021 10:00:53 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51469 Mon 13 May 2024 11:58:11 AEST ]]>